nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethobenzamide—Sensitisation—Tretinoin—peripheral nervous system neoplasm	0.0794	0.0822	CcSEcCtD
Trimethobenzamide—Sensitisation—Isotretinoin—peripheral nervous system neoplasm	0.0794	0.0822	CcSEcCtD
Trimethobenzamide—Sensitisation—Alitretinoin—peripheral nervous system neoplasm	0.0601	0.0623	CcSEcCtD
Trimethobenzamide—Sensitisation—Epirubicin—peripheral nervous system neoplasm	0.0263	0.0273	CcSEcCtD
Trimethobenzamide—Coma—Tretinoin—peripheral nervous system neoplasm	0.0259	0.0268	CcSEcCtD
Trimethobenzamide—Coma—Isotretinoin—peripheral nervous system neoplasm	0.0259	0.0268	CcSEcCtD
Trimethobenzamide—Sensitisation—Doxorubicin—peripheral nervous system neoplasm	0.0243	0.0252	CcSEcCtD
Trimethobenzamide—Coma—Alitretinoin—peripheral nervous system neoplasm	0.0196	0.0203	CcSEcCtD
Trimethobenzamide—Coma—Vincristine—peripheral nervous system neoplasm	0.0189	0.0196	CcSEcCtD
Trimethobenzamide—Cramp muscle—Topotecan—peripheral nervous system neoplasm	0.0187	0.0193	CcSEcCtD
Trimethobenzamide—Drowsiness—Tretinoin—peripheral nervous system neoplasm	0.0159	0.0164	CcSEcCtD
Trimethobenzamide—Drowsiness—Isotretinoin—peripheral nervous system neoplasm	0.0159	0.0164	CcSEcCtD
Trimethobenzamide—Jaundice—Melphalan—peripheral nervous system neoplasm	0.0153	0.0158	CcSEcCtD
Trimethobenzamide—Trimethoprim—ABCB1—peripheral nervous system neoplasm	0.0148	0.428	CrCbGaD
Trimethobenzamide—Colchicine—ABCB1—peripheral nervous system neoplasm	0.0137	0.395	CrCbGaD
Trimethobenzamide—Drowsiness—Alitretinoin—peripheral nervous system neoplasm	0.012	0.0124	CcSEcCtD
Trimethobenzamide—Muscle spasms—Topotecan—peripheral nervous system neoplasm	0.012	0.0124	CcSEcCtD
Trimethobenzamide—Cramp muscle—Cisplatin—peripheral nervous system neoplasm	0.012	0.0124	CcSEcCtD
Trimethobenzamide—Vision blurred—Tretinoin—peripheral nervous system neoplasm	0.0117	0.0121	CcSEcCtD
Trimethobenzamide—Vision blurred—Isotretinoin—peripheral nervous system neoplasm	0.0117	0.0121	CcSEcCtD
Trimethobenzamide—Blood disorder—Epirubicin—peripheral nervous system neoplasm	0.0113	0.0117	CcSEcCtD
Trimethobenzamide—Cramp muscle—Etoposide—peripheral nervous system neoplasm	0.011	0.0114	CcSEcCtD
Trimethobenzamide—Convulsion—Tretinoin—peripheral nervous system neoplasm	0.0107	0.0111	CcSEcCtD
Trimethobenzamide—Convulsion—Isotretinoin—peripheral nervous system neoplasm	0.0107	0.0111	CcSEcCtD
Trimethobenzamide—Convulsion—Melphalan—peripheral nervous system neoplasm	0.0106	0.011	CcSEcCtD
Trimethobenzamide—Blood disorder—Doxorubicin—peripheral nervous system neoplasm	0.0104	0.0108	CcSEcCtD
Trimethobenzamide—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.00945	0.00979	CcSEcCtD
Trimethobenzamide—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.00945	0.00979	CcSEcCtD
Trimethobenzamide—Hypotension—Melphalan—peripheral nervous system neoplasm	0.00933	0.00966	CcSEcCtD
Trimethobenzamide—Jaundice—Etoposide—peripheral nervous system neoplasm	0.00914	0.00947	CcSEcCtD
Trimethobenzamide—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00899	0.00931	CcSEcCtD
Trimethobenzamide—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00899	0.00931	CcSEcCtD
Trimethobenzamide—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.00885	0.00917	CcSEcCtD
Trimethobenzamide—Coma—Epirubicin—peripheral nervous system neoplasm	0.00859	0.0089	CcSEcCtD
Trimethobenzamide—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.00814	0.00843	CcSEcCtD
Trimethobenzamide—Coma—Doxorubicin—peripheral nervous system neoplasm	0.00795	0.00823	CcSEcCtD
Trimethobenzamide—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00784	0.00812	CcSEcCtD
Trimethobenzamide—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.00769	0.00797	CcSEcCtD
Trimethobenzamide—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00754	0.00781	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00751	0.00778	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00745	0.00772	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00745	0.00772	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00735	0.00762	CcSEcCtD
Trimethobenzamide—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00716	0.00742	CcSEcCtD
Trimethobenzamide—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.00705	0.0073	CcSEcCtD
Trimethobenzamide—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00697	0.00722	CcSEcCtD
Trimethobenzamide—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00693	0.00718	CcSEcCtD
Trimethobenzamide—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00692	0.00717	CcSEcCtD
Trimethobenzamide—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00692	0.00717	CcSEcCtD
Trimethobenzamide—Hypotension—Vincristine—peripheral nervous system neoplasm	0.0069	0.00715	CcSEcCtD
Trimethobenzamide—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00683	0.00707	CcSEcCtD
Trimethobenzamide—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00681	0.00706	CcSEcCtD
Trimethobenzamide—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00674	0.00698	CcSEcCtD
Trimethobenzamide—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00669	0.00693	CcSEcCtD
Trimethobenzamide—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00669	0.00693	CcSEcCtD
Trimethobenzamide—Headache—Topotecan—peripheral nervous system neoplasm	0.00639	0.00661	CcSEcCtD
Trimethobenzamide—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00635	0.00658	CcSEcCtD
Trimethobenzamide—Headache—Tretinoin—peripheral nervous system neoplasm	0.00633	0.00656	CcSEcCtD
Trimethobenzamide—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00633	0.00656	CcSEcCtD
Trimethobenzamide—Verapamil—ABCB1—peripheral nervous system neoplasm	0.00612	0.177	CrCbGaD
Trimethobenzamide—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.0061	0.00632	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00609	0.00631	CcSEcCtD
Trimethobenzamide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00565	0.00586	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00565	0.00585	CcSEcCtD
Trimethobenzamide—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00559	0.00579	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00544	0.00564	CcSEcCtD
Trimethobenzamide—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00532	0.00551	CcSEcCtD
Trimethobenzamide—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.00526	0.00545	CcSEcCtD
Trimethobenzamide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00524	0.00543	CcSEcCtD
Trimethobenzamide—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.00512	0.00531	CcSEcCtD
Trimethobenzamide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00507	0.00525	CcSEcCtD
Trimethobenzamide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00505	0.00523	CcSEcCtD
Trimethobenzamide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00488	0.00506	CcSEcCtD
Trimethobenzamide—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.00486	0.00504	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00481	0.00498	CcSEcCtD
Trimethobenzamide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.0048	0.00497	CcSEcCtD
Trimethobenzamide—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.00474	0.00491	CcSEcCtD
Trimethobenzamide—Headache—Vincristine—peripheral nervous system neoplasm	0.00463	0.00479	CcSEcCtD
Trimethobenzamide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00447	0.00463	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00441	0.00456	CcSEcCtD
Trimethobenzamide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00409	0.00424	CcSEcCtD
Trimethobenzamide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00396	0.0041	CcSEcCtD
Trimethobenzamide—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.00395	0.00409	CcSEcCtD
Trimethobenzamide—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.00387	0.00401	CcSEcCtD
Trimethobenzamide—Headache—Etoposide—peripheral nervous system neoplasm	0.00375	0.00388	CcSEcCtD
Trimethobenzamide—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.00365	0.00379	CcSEcCtD
Trimethobenzamide—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.00358	0.00371	CcSEcCtD
Trimethobenzamide—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.00356	0.00369	CcSEcCtD
Trimethobenzamide—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.00329	0.00341	CcSEcCtD
Trimethobenzamide—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.00313	0.00325	CcSEcCtD
Trimethobenzamide—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00298	0.00309	CcSEcCtD
Trimethobenzamide—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.0029	0.003	CcSEcCtD
Trimethobenzamide—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.00276	0.00286	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00247	0.00256	CcSEcCtD
Trimethobenzamide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.00229	0.00238	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00229	0.00237	CcSEcCtD
Trimethobenzamide—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00222	0.0023	CcSEcCtD
Trimethobenzamide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00212	0.0022	CcSEcCtD
Trimethobenzamide—Headache—Epirubicin—peripheral nervous system neoplasm	0.0021	0.00218	CcSEcCtD
Trimethobenzamide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00205	0.00213	CcSEcCtD
Trimethobenzamide—Headache—Doxorubicin—peripheral nervous system neoplasm	0.00194	0.00201	CcSEcCtD
